| Stay updated on the top DIGITAL HEALTH NEWS |
|---|
|
|
The Innovative Medicines Initiative (IMI) has launched its 100th project in the form of Hypo-RESOLVE, a 4 year, EUR 26.8 million project on diabetes. The milestone comes as IMI celebrates its 10th anniversary with a series of events and activities. The IMI project portfolio is diverse; many projects, like Hypo-RESOLVE, focus on specific health issues such as diabetes, neurological conditions (including dementia, depression, and pain), cancer, auto-immune diseases (such as rheumatoid arthritis), and infectious diseases (including antimicrobial resistance and Ebola).
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and US-based Emory Healthcare have launched a new remote Intensive Care Unit (eICU) monitoring program, based at the Royal Perth Hospital in Western Australia, focused on improving the outcomes of high risk patients and advancing the globalization of critical care.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands, that has developed an innovative, easy to use device to treat positional obstructive sleep apnea and positional snoring. Financial details of the transaction were not disclosed.